SCHEMBL25980210

SCHEMBL25980210

c1ccc(-c2cccc(N(c3ccccc3)c3cccc(-c4cccc5c4oc4cc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)ccc45)c3)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
PRKDC P78527 4/20 0.39
GGPS1 O95749 1/20 0.35
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
PTGES2 Q9H7Z7 1/20 0.33
PIM1 P11309 1/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
PIM3 Q86V86 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
POLB P06746 2/20 0.32
HCRTR1 O43613 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
MAPT P10636 3/20 0.32
TSHR P16473 2/20 0.32
TP53 P04637 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25980209 0.98 ALOX5 (0.43) ALOX5PRKDCGGPS1MMP12MMP13
SCHEMBL25980189 0.98 ALOX5 (0.44) ALOX5PRKDCGGPS1PTGES2KDM4E
SCHEMBL25980139 0.93 ALOX5 (0.41) ALOX5PRKDCGGPS1MMP12MMP13
SCHEMBL25980211 0.92 ALOX5 (0.40) ALOX5PRKDCGGPS1PTGES2KDM4E
SCHEMBL26416738 0.91 ALOX5 (0.39) ALOX5PRKDCGGPS1PIM1CSNK2A2
SCHEMBL19543760 0.90 ALOX5 (0.51) ALOX5PRKDCGGPS1MMP12MMP13
SCHEMBL24216510 0.90 ALOX5 (0.49) ALOX5PRKDCGGPS1MMP12MMP13
SCHEMBL23623770 0.90 ALOX5 (0.49) ALOX5PRKDCGGPS1MMP12MMP13
SCHEMBL25980212 0.89 ALOX5 (0.40) ALOX5PRKDCGGPS1PTGES2KDM4E
SCHEMBL25979934 0.89 ALOX5 (0.41) ALOX5PRKDCGGPS1MMP12MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 ALOX5 660/4885PRKDC 4556/4885GGPS1 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.